93 related articles for article (PubMed ID: 19377514)
21. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
Goto T; Ikuta K; Inamoto Y; Kamoshita S; Yokohata E; Koyama D; Onodera K; Seto A; Watanabe K; Imahashi N; Tsukamoto S; Ozawa Y; Sasaki K; Ito M; Kohgo Y; Miyamura K
Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
[TBL] [Abstract][Full Text] [Related]
22. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
Malcovati L
Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
[TBL] [Abstract][Full Text] [Related]
23. Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.
Tefferi A; Mesa RA; Pardanani A; Hussein K; Schwager S; Hanson CA; Steensma DP
Am J Hematol; 2009 May; 84(5):265-7. PubMed ID: 19396855
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
25. Iron-overload in long-term survivors of hematopoietic transplantation.
Kamble R; Mims M
Bone Marrow Transplant; 2006 Apr; 37(8):805-6. PubMed ID: 16518421
[No Abstract] [Full Text] [Related]
26. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
Taher A; Musallam KM; El Rassi F; Duca L; Inati A; Koussa S; Cappellini MD
Br J Haematol; 2009 Sep; 146(5):569-72. PubMed ID: 19604239
[TBL] [Abstract][Full Text] [Related]
27. Soluble transferrin receptors and ferritin in Type 2 diabetic patients.
Hernández C; Lecube A; Carrera A; Simó R
Diabet Med; 2005 Jan; 22(1):97-101. PubMed ID: 15606699
[TBL] [Abstract][Full Text] [Related]
28. Total body iron overload in welder's siderosis.
Doherty MJ; Healy M; Richardson SG; Fisher NC
Occup Environ Med; 2004 Jan; 61(1):82-5. PubMed ID: 14691279
[TBL] [Abstract][Full Text] [Related]
29. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
30. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload.
Ozyilmaz E; Aydogdu M; Sucak G; Aki SZ; Ozkurt ZN; Yegin ZA; Kokturk N
Bone Marrow Transplant; 2010 Oct; 45(10):1528-33. PubMed ID: 20118991
[TBL] [Abstract][Full Text] [Related]
32. Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity.
de la Serna J; Bornstein R; García-Bueno MJ; Lahuerta-Palacios JJ
Bone Marrow Transplant; 1999 Jan; 23(1):95-7. PubMed ID: 10037058
[TBL] [Abstract][Full Text] [Related]
33. A magnetic resonance imaging study of iron overload in hemopoietic stem cell transplant recipients with increased ferritin levels.
Au WY; Lam WM; Chu WC; Tam S; Wong WK; Pennell DJ; Lie AK; Liang R
Transplant Proc; 2007 Dec; 39(10):3369-74. PubMed ID: 18089387
[TBL] [Abstract][Full Text] [Related]
34. Iron overload in patients with chronic viral hepatitis: how common is it?
Riggio O; Montagnese F; Fiore P; Folino S; Giambartolomei S; Gandin C; Merli M; Quinti I; Violante N; Caroli S; Senofonte O; Capocaccia L
Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
[TBL] [Abstract][Full Text] [Related]
35. Men with hyperferritinemia and diabetes in the Mediterranean area do not have a higher iron overload than those without diabetes.
Freixenet N; Vilardell C; Llauradó G; Giménez-Palop O; Berlanga E; Gutiérrez C; Caixàs A; Vendrell J; González-Clemente JM
Diabetes Res Clin Pract; 2011 Feb; 91(2):e33-6. PubMed ID: 21055836
[TBL] [Abstract][Full Text] [Related]
36. Abnormally high serum ferritin levels among professional road cyclists.
Zotter H; Robinson N; Zorzoli M; Schattenberg L; Saugy M; Mangin P
Br J Sports Med; 2004 Dec; 38(6):704-8. PubMed ID: 15562163
[TBL] [Abstract][Full Text] [Related]
37. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.
Friedman TM; Varadi G; Hopely DD; Filicko J; Wagner J; Ferber A; Martinez J; Brunner J; Grosso D; McGuire L; Korngold R; Flomenberg N
Biol Blood Marrow Transplant; 2001; 7(12):656-64. PubMed ID: 11787528
[TBL] [Abstract][Full Text] [Related]
38. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Karakan T; Akyol G
Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
[TBL] [Abstract][Full Text] [Related]
39. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
[TBL] [Abstract][Full Text] [Related]
40. Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome.
Murphy PT; Mitra S; Gleeson M; Desmond R; Swinkels DW
Br J Haematol; 2009 Feb; 144(3):451-2. PubMed ID: 19076175
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
